Bronchiolitis obliterans syndrome occurs earlier in the post-lung allocation score era

Abbas Emaminia, Sara A. Hennessy, Tjasa Hranjec, Damien J. Lapar, Benjamin D. Kozower, David R. Jones, Irving L. Kron, Christine L. Lau

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: In 2005, the time-based waiting list for lung transplantation was replaced by an illness/benefit lung allocation score (LAS). Although short-term outcomes after transplantation have been reported to be similar before and after the new system, little is known about long-term results. The objective of this study was to evaluate the impact of LAS on the development of bronchiolitis obliterans syndrome as well as on overall 3-year and bronchiolitis obliterans syndrome-related survival. Methods: Data obtained from the United Network for Organ Sharing were used to review 8091 patients who underwent lung transplantation from 2002 to 2008. Patients were stratified according to time of transplantation into those treated before initiation of the LAS (pre-LAS group, January 2002-April 2005, n = 3729) and those treated after implementation of the score (post-LAS group, May 2005-May 2008, n = 4362). Overall, 3-year survivals for patient groups were compared using a univariate analysis, Cox proportional hazards model to generate a relative risk, and Kaplan-Meier curve analyses. Results: During the 3-year follow-up period, bronchiolitis obliterans syndrome developed in 22% of lung transplant recipients (n = 1801). Although the incidence of postoperative bronchiolitis obliterans syndrome development was similar between groups, post-LAS patients incurred fewer bronchiolitis obliterans syndrome-free days (609 ± 7.5 vs 682 ± 9; P <.0001; log-rank test P = .0108) than did pre-LAS patients. Overall 3-year survival was lower in post-LAS patients and approached statistical significance (P = .05). Similarly, bronchiolitis obliterans syndrome-related survival was worse for patients in the post-LAS group (log-rank test P = .01). Conclusions: In the current LAS era, lung transplant recipients have significantly fewer bronchiolitis obliterans syndrome-free days after 3-year follow-up. Compared with the pre-LAS population, overall and bronchiolitis obliterans syndrome-related survival appears worse in the post-LAS era. Limitation of known risk factors for development of bronchiolitis obliterans syndrome-may prove even more important in this patient population.

Original languageEnglish (US)
Pages (from-to)1278-1282
Number of pages5
JournalJournal of Thoracic and Cardiovascular Surgery
Volume141
Issue number5
DOIs
StatePublished - May 2011

Fingerprint

Bronchiolitis Obliterans
Lung
Survival
Lung Transplantation
Transplantation
Waiting Lists
Kaplan-Meier Estimate
Proportional Hazards Models

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Cite this

Bronchiolitis obliterans syndrome occurs earlier in the post-lung allocation score era. / Emaminia, Abbas; Hennessy, Sara A.; Hranjec, Tjasa; Lapar, Damien J.; Kozower, Benjamin D.; Jones, David R.; Kron, Irving L.; Lau, Christine L.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 141, No. 5, 05.2011, p. 1278-1282.

Research output: Contribution to journalArticle

Emaminia, Abbas ; Hennessy, Sara A. ; Hranjec, Tjasa ; Lapar, Damien J. ; Kozower, Benjamin D. ; Jones, David R. ; Kron, Irving L. ; Lau, Christine L. / Bronchiolitis obliterans syndrome occurs earlier in the post-lung allocation score era. In: Journal of Thoracic and Cardiovascular Surgery. 2011 ; Vol. 141, No. 5. pp. 1278-1282.
@article{ed3993be58d5436e913d6580068469f7,
title = "Bronchiolitis obliterans syndrome occurs earlier in the post-lung allocation score era",
abstract = "Objectives: In 2005, the time-based waiting list for lung transplantation was replaced by an illness/benefit lung allocation score (LAS). Although short-term outcomes after transplantation have been reported to be similar before and after the new system, little is known about long-term results. The objective of this study was to evaluate the impact of LAS on the development of bronchiolitis obliterans syndrome as well as on overall 3-year and bronchiolitis obliterans syndrome-related survival. Methods: Data obtained from the United Network for Organ Sharing were used to review 8091 patients who underwent lung transplantation from 2002 to 2008. Patients were stratified according to time of transplantation into those treated before initiation of the LAS (pre-LAS group, January 2002-April 2005, n = 3729) and those treated after implementation of the score (post-LAS group, May 2005-May 2008, n = 4362). Overall, 3-year survivals for patient groups were compared using a univariate analysis, Cox proportional hazards model to generate a relative risk, and Kaplan-Meier curve analyses. Results: During the 3-year follow-up period, bronchiolitis obliterans syndrome developed in 22{\%} of lung transplant recipients (n = 1801). Although the incidence of postoperative bronchiolitis obliterans syndrome development was similar between groups, post-LAS patients incurred fewer bronchiolitis obliterans syndrome-free days (609 ± 7.5 vs 682 ± 9; P <.0001; log-rank test P = .0108) than did pre-LAS patients. Overall 3-year survival was lower in post-LAS patients and approached statistical significance (P = .05). Similarly, bronchiolitis obliterans syndrome-related survival was worse for patients in the post-LAS group (log-rank test P = .01). Conclusions: In the current LAS era, lung transplant recipients have significantly fewer bronchiolitis obliterans syndrome-free days after 3-year follow-up. Compared with the pre-LAS population, overall and bronchiolitis obliterans syndrome-related survival appears worse in the post-LAS era. Limitation of known risk factors for development of bronchiolitis obliterans syndrome-may prove even more important in this patient population.",
author = "Abbas Emaminia and Hennessy, {Sara A.} and Tjasa Hranjec and Lapar, {Damien J.} and Kozower, {Benjamin D.} and Jones, {David R.} and Kron, {Irving L.} and Lau, {Christine L.}",
year = "2011",
month = "5",
doi = "10.1016/j.jtcvs.2010.12.025",
language = "English (US)",
volume = "141",
pages = "1278--1282",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Bronchiolitis obliterans syndrome occurs earlier in the post-lung allocation score era

AU - Emaminia, Abbas

AU - Hennessy, Sara A.

AU - Hranjec, Tjasa

AU - Lapar, Damien J.

AU - Kozower, Benjamin D.

AU - Jones, David R.

AU - Kron, Irving L.

AU - Lau, Christine L.

PY - 2011/5

Y1 - 2011/5

N2 - Objectives: In 2005, the time-based waiting list for lung transplantation was replaced by an illness/benefit lung allocation score (LAS). Although short-term outcomes after transplantation have been reported to be similar before and after the new system, little is known about long-term results. The objective of this study was to evaluate the impact of LAS on the development of bronchiolitis obliterans syndrome as well as on overall 3-year and bronchiolitis obliterans syndrome-related survival. Methods: Data obtained from the United Network for Organ Sharing were used to review 8091 patients who underwent lung transplantation from 2002 to 2008. Patients were stratified according to time of transplantation into those treated before initiation of the LAS (pre-LAS group, January 2002-April 2005, n = 3729) and those treated after implementation of the score (post-LAS group, May 2005-May 2008, n = 4362). Overall, 3-year survivals for patient groups were compared using a univariate analysis, Cox proportional hazards model to generate a relative risk, and Kaplan-Meier curve analyses. Results: During the 3-year follow-up period, bronchiolitis obliterans syndrome developed in 22% of lung transplant recipients (n = 1801). Although the incidence of postoperative bronchiolitis obliterans syndrome development was similar between groups, post-LAS patients incurred fewer bronchiolitis obliterans syndrome-free days (609 ± 7.5 vs 682 ± 9; P <.0001; log-rank test P = .0108) than did pre-LAS patients. Overall 3-year survival was lower in post-LAS patients and approached statistical significance (P = .05). Similarly, bronchiolitis obliterans syndrome-related survival was worse for patients in the post-LAS group (log-rank test P = .01). Conclusions: In the current LAS era, lung transplant recipients have significantly fewer bronchiolitis obliterans syndrome-free days after 3-year follow-up. Compared with the pre-LAS population, overall and bronchiolitis obliterans syndrome-related survival appears worse in the post-LAS era. Limitation of known risk factors for development of bronchiolitis obliterans syndrome-may prove even more important in this patient population.

AB - Objectives: In 2005, the time-based waiting list for lung transplantation was replaced by an illness/benefit lung allocation score (LAS). Although short-term outcomes after transplantation have been reported to be similar before and after the new system, little is known about long-term results. The objective of this study was to evaluate the impact of LAS on the development of bronchiolitis obliterans syndrome as well as on overall 3-year and bronchiolitis obliterans syndrome-related survival. Methods: Data obtained from the United Network for Organ Sharing were used to review 8091 patients who underwent lung transplantation from 2002 to 2008. Patients were stratified according to time of transplantation into those treated before initiation of the LAS (pre-LAS group, January 2002-April 2005, n = 3729) and those treated after implementation of the score (post-LAS group, May 2005-May 2008, n = 4362). Overall, 3-year survivals for patient groups were compared using a univariate analysis, Cox proportional hazards model to generate a relative risk, and Kaplan-Meier curve analyses. Results: During the 3-year follow-up period, bronchiolitis obliterans syndrome developed in 22% of lung transplant recipients (n = 1801). Although the incidence of postoperative bronchiolitis obliterans syndrome development was similar between groups, post-LAS patients incurred fewer bronchiolitis obliterans syndrome-free days (609 ± 7.5 vs 682 ± 9; P <.0001; log-rank test P = .0108) than did pre-LAS patients. Overall 3-year survival was lower in post-LAS patients and approached statistical significance (P = .05). Similarly, bronchiolitis obliterans syndrome-related survival was worse for patients in the post-LAS group (log-rank test P = .01). Conclusions: In the current LAS era, lung transplant recipients have significantly fewer bronchiolitis obliterans syndrome-free days after 3-year follow-up. Compared with the pre-LAS population, overall and bronchiolitis obliterans syndrome-related survival appears worse in the post-LAS era. Limitation of known risk factors for development of bronchiolitis obliterans syndrome-may prove even more important in this patient population.

UR - http://www.scopus.com/inward/record.url?scp=79954580567&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954580567&partnerID=8YFLogxK

U2 - 10.1016/j.jtcvs.2010.12.025

DO - 10.1016/j.jtcvs.2010.12.025

M3 - Article

C2 - 21320711

AN - SCOPUS:79954580567

VL - 141

SP - 1278

EP - 1282

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 5

ER -